Despite clear clinical promise, precision oncology adoption is often stalled by persistent payer coverage gaps and disjointed clinical workflows. This session unpacks where friction most often occurs, from testing authorization to results interpretation, and shares strategies health systems are using to close those gaps and scale personalized cancer treatment.